Clinical research is a complex, expensive, and time- and resourceintensive process. Feasibility assessments play a crucial part in this clinical research planning process as it enables the sponsors and contract research organisations (CROs) to evaluate the possibility of conducting clinical research in a particular region or country. Bee Ying Tan, Audrey Ooi, and Noorzaihan Mat Radi at Clinical Research Malaysia put together a report on the reasons behind feasibility rejection.